Showing 481 - 500 results of 29,492 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 5 ((nm decrease) OR (nn decrease)) ))', query time: 0.91s Refine Results
  1. 481
  2. 482
  3. 483
  4. 484
  5. 485
  6. 486
  7. 487

    Presentation_1_Airway macrophages display decreased expression of receptors mediating and regulating scavenging in early cystic fibrosis lung disease.pdf by Lisa J. M. Slimmen (16464600)

    Published 2023
    “…The effect of age and neutrophilic inflammation, among other variables, on marker expression was assessed with a multivariate linear regression model.</p>Results<p>AM expression of scavenger receptor CD163 decreased with age (p = 0.016) and was negatively correlated with BALF %neutrophils (r = -0.34, p = 0.016). …”
  8. 488
  9. 489
  10. 490

    Differences among the classes of CAMs. by Daniel P. Bradley (10306893)

    Published 2025
    “…Some <i>N</i>-hydroxypyridinedione (HPD) HBV RNaseH inhibitors significantly reduced accumulation of capsids in HBV-replicating cells. A representative HPD <b>1466</b>, with a 50% effective concentration against HBV replication of 0.25 µM, decreased capsid and core protein accumulation by 50–90% in HepDES19 and HepG2.2.15 cells. …”
  11. 491

    Effects of intracellular treatment with 5- or 40-nm AuNPs on AP properties in hippocampal CA1 neurons. by Seungmoon Jung (534987)

    Published 2014
    “…<p>(A) AuNPs of both sizes significantly decreased the latency to the first AP. The 40-nm AuNPs significantly reduced the AP threshold (B) and AP duration (C). …”
  12. 492
  13. 493
  14. 494
  15. 495
  16. 496
  17. 497
  18. 498
  19. 499
  20. 500

    DataSheet_2_A cyclic peptide-based PROTAC induces intracellular degradation of palmitoyltransferase and potently decreases PD-L1 expression in human cervical cancer cells.docx by Yu-Ying Shi (15975992)

    Published 2023
    “…Introduction<p>Our previous research has found that degradation of palmitoyltransferase in tumor cells using a linear peptide PROTAC leads to a significant decrease in PD-L1 expression in tumors. …”